These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6624772)

  • 21. Adrenal cortical scintigraphy for lateralization of bilateral adrenal nodules in primary aldosteronism.
    Hwang I; Chong A; Kim JB; Kim KH; Kwon D
    Korean J Urol; 2014 Aug; 55(8):551-3. PubMed ID: 25132951
    [No Abstract]   [Full Text] [Related]  

  • 22. The value of scintigraphy and computed tomography for the differential diagnosis of primary hyperaldosteronism.
    Hietakorpi S; Korhonen T; Aro A; Lampainen E; Alhava E; Karjalainen P; Wiljasalo S
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):118-22. PubMed ID: 3766043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenal scintigraphy in primary aldosteronism. Improved visualization after long-term pre-treatment with dexamethasone.
    Hoefnagels WH; Claessens RA; Corstens FH; Drayer JI; Kazem I; Kloppenborg PW
    Nuklearmedizin; 1981 Apr; 20(2):76-81. PubMed ID: 7243603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scintigraphic diagnosis of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Dominguez-Gadea L; Diez L; Piedrola-Maroto G; Crespo A
    Nucl Med Commun; 1996 Jan; 17(1):29-32. PubMed ID: 8692469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of localizing examinations used in the diagnosis of primary hyperaldosteronism].
    Feltynowski T; Chodakowska J; Januszewicz W; Ignatowska-Switalska H; Wocial B; Pruszyński B; Jakubowski W; Leowska E; Pacho R; Bar-Andziak E
    Pol Tyg Lek; 1989 Jul 23-30; 44(30-31):710-4. PubMed ID: 2701748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adrenocortical scintigraphy with 131I-19-iodocholesterol. Indications and results in 66 cases of hypercortisolism and hyperaldosteronism (author's transl)].
    Leger FA; Requeda E; Reach G; Plouin PF; Savoie JC
    Nouv Presse Med; 1981 Feb; 10(6):395-9. PubMed ID: 7220332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nuclear medicine methods for the diagnosis of adrenal tumors].
    Gregianin M; Bui F; Varotto L; Zucchetta P; Macri C
    Minerva Endocrinol; 1995 Mar; 20(1):27-38. PubMed ID: 7651280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cushing's syndrome due to unilateral adrenocortical hyperplasia.
    Otsuka F; Ogura T; Nakao K; Hayakawa N; Mimura Y; Yamauchi T; Makino H
    Intern Med; 1998 Apr; 37(4):385-90. PubMed ID: 9630199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adrenocortical scintigraphy to evaluate incidental adrenal mass (incidentaloma) discovered on computed tomography].
    Tsukamoto E; Itoh K; Furudate M
    Kaku Igaku; 1991 Jun; 28(6):629-34. PubMed ID: 1895559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary bilateral adrenocortical causes of Cushing's syndrome.
    Zeiger MA; Nieman LK; Cutler GB; Chrousos GP; Doppman JL; Travis WD; Norton JA
    Surgery; 1991 Dec; 110(6):1106-15. PubMed ID: 1745978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenal scintigraphy with 75Se selenonorcholestenol: a review.
    Sudell CJ; Blake GM; Gossage AA; Cullen DR; Munro DS
    Nucl Med Commun; 1985 Sep; 6(9):519-27. PubMed ID: 4069475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenocortical SPECT using iodine-131 NP-59.
    Hwang I; Balingit AG; Georgitis WJ; Sisson JC; Shapiro B
    J Nucl Med; 1998 Aug; 39(8):1460-3. PubMed ID: 9708530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tomographic evaluation of [131I] 6beta-iodomethyl-norcholesterol standardised uptake trend in clinically silent monolateral and bilateral adrenocortical incidentalomas.
    Imperiale A; Olianti C; Mannelli M; La Cava G; Pupi A
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):287-96. PubMed ID: 16172575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on adrenal scanning agents, 131I-adosterol (author's transl)].
    Yonahara Y; Takahara Y; Sasaki Y; Kirimura H; Sato A
    Radioisotopes; 1977 Feb; 26(2):102-5. PubMed ID: 577028
    [No Abstract]   [Full Text] [Related]  

  • 35. Adrenal scintigraphy of well-differentiated (functioning) adrenocortical carcinomas: potential surgical pitfalls.
    Pasieka JL; McLeod MK; Thompson NW; Gross MD; Schteingart DE
    Surgery; 1992 Nov; 112(5):884-90. PubMed ID: 1440240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging.
    Kazerooni EA; Sisson JC; Shapiro B; Gross MD; Driedger A; Hurwitz GA; Mattar AG; Petry NA
    J Nucl Med; 1990 Apr; 31(4):526-34. PubMed ID: 2324830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal cortical adenoma causing Cushing's syndrome: correct localization by functional scintigraphy despite nonlocalizing morphological imaging studies.
    Geatti O; Fig L; Shapiro B
    Clin Nucl Med; 1990 Mar; 15(3):168-71. PubMed ID: 2317996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.
    Valk TW; Gross MD; Freitas JE; Swanson DP; Schteingart DE; Beierwaltes WH
    J Nucl Med; 1980 Nov; 21(11):1069-72. PubMed ID: 7431105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of parmacologic manipulation in adrenal cortical scintigraphy.
    Gross MD; Valk TW; Swanson DP; Thrall JH; Grekin RJ; Beirewaltes WH
    Semin Nucl Med; 1981 Apr; 11(2):128-48. PubMed ID: 7244660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cushing with transition from pituitary to adrenal origin. Study with SPECT scintigraphy of the adrenal cortex with norcholesterol-I 131 in a case].
    Araya V; Jofré J; Hidalgo P; Massardo T; Amat J; Pumarino H
    Rev Med Chil; 1998 Sep; 126(9):1103-7. PubMed ID: 9922515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.